Lilly warns public not to use tirzepatide for cosmetic weight loss

Eli Lilly and Co. released an open letter stating its tirzepatide products should not be used for cosmetic weight loss and warning the public about the circulation of compounded and counterfeit tirzepatide.
“Patient safety is Lilly’s top priority, and we actively engage in monitoring, evaluating and reporting safety information for all our medicines,” the letter stated. “We are aware of certain practices relating to our tirzepatide medicines that we wish to address publicly to ensure that our medicines are prescribed and used safely.”
As Healio previously reported,

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart